Invesco Biotechnology & Genome ETF
PBE
PBE
96 hedge funds and large institutions have $88M invested in Invesco Biotechnology & Genome ETF in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 31
Holders
96
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.98M | |
| 2 | +$569K | |
| 3 | +$434K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$296K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$250K |
Top Sellers
| 1 | -$341K | |
| 2 | -$333K | |
| 3 | -$295K | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$252K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$252K |